SOPHiA GENETICS SA Cash Flows From Used In Investing Activities
SOPHiA GENETICS SA (SOPH) reported Cash Flows From Used In Investing Activities of -$8.67 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-03-03
| Period end | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 6 month as first filed | Cash Flows From Used In Investing Activities 12 month | Cash Flows From Used In Investing Activities 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -$8.67M 20-F · filed 2026-03-03 | |||
| 2025-06-30 | -$2.59M 6-K · filed 2025-08-05 | |||
| 2024-12-31 | -$4.75M 20-F · filed 2026-03-03 | -$8.18M 20-F · filed 2025-03-04 | ||
| 2024-06-30 | -$2.12M 6-K · filed 2025-08-05 | -$3.92M 6-K · filed 2024-08-06 | ||
| 2023-12-31 | $12.97M 20-F · filed 2026-03-03 | $8.32M 20-F · filed 2024-03-05 | ||
| 2023-06-30 | $12.67M 6-K · filed 2024-08-06 | |||
| 2022-12-31 | $41.97M 20-F · filed 2025-03-04 | |||
| 2022-06-30 | $26.70M 6-K · filed 2023-08-08 | |||
| 2021-12-31 | -$56.93M 20-F · filed 2024-03-05 | |||
| 2020-12-31 | -$24.32M 20-F · filed 2023-03-07 | |||
| 2019-12-31 | -$3.03M 20-F · filed 2022-03-15 |